|
|||||
|
|
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel |
|
| Authors: | Aghajani Marjan Mokhtarzadeh Ahad Aghebati-Maleki Leili Mansoori Behzad Mohammadi Ali Safaei Sahar Asadzadeh Zahra Hajiasgharzadeh Khalil Khaze Shahgoli Vahid Baradaran Behzad |
| Affiliation: | 1.Immunology Research Center, Tabriz University of Medical Sciences, Daneshghah Ave, Tabriz, Iran ;2.Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark ;3.Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran ; |
| Abstract: | Molecular Biology Reports - One of the major barriers in cancer therapy is the resistance to conventional therapies and cancer stem cells (CSCs) are among the main causes of this problem. CD133 as... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |